Results 31 to 40 of about 151 (97)

The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study

, 2006
International Wound Journal, Volume 3, Issue 3, Page 191-192, September 2006.
wiley   +1 more source

Diabetic foot screening: why is it neglected?

, 2006
International Wound Journal, Volume 3, Issue 3, Page 192-193, September 2006.
wiley   +1 more source

Altered skin blood perfusion in areas with non blanchable erythema: an explorative study

, 2006
International Wound Journal, Volume 3, Issue 3, Page 193-195, September 2006.
wiley   +1 more source

Multiple bacterial species reside in chronic wounds: a longitudinal study

, 2006
International Wound Journal, Volume 3, Issue 3, Page 195-196, September 2006.
wiley   +1 more source

Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds

, 2006
International Wound Journal, Volume 3, Issue 3, Page 196-199, September 2006.
wiley   +1 more source

Validation of a diabetic foot surgery classification

, 2006
International Wound Journal, Volume 3, Issue 3, Page 199-200, September 2006.
wiley   +1 more source

Healing of large midline wounds in infants: unlike in adults, does conservative approach gives better results? Two case reports and review of the literature

, 2006
International Wound Journal, Volume 3, Issue 3, Page 200-201, September 2006.
wiley   +1 more source

[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra^® 2.0]. [PDF]

J Prev Med Hyg, 2022
Calabrò GE, Boccalini S, Bechini A, Panatto D, Domnich A, Lai PL, Amicizia D, Rizzo C, Pugliese A, DI Pietro ML, Zanella B, Parente F, Trombetta CS, Saraceno G, Sottile S, Abreha FM, Giacchetta I, Properzi S, Santolini G, D'Ambrosio F, Maida A, Scardigno A, LA Gatta E, Petrella L, Bonanni P, DE Waure C.   +25 more
europepmc   +1 more source

Costo-efficacia di IMI/CIL/REL rispetto a CMS+IMI per il trattamento di infezioni batteriche Gram-negative non sensibili ai carbapenemi. [PDF]

Glob Reg Health Technol Assess, 2023
Paoletti M, Marcellusi A, Yang J, Mennini FS.   +3 more
europepmc   +1 more source

[The new 15-valent pneumococcal conjugate vaccine for the prevention of S. pneumoniae infections in pediatric age: a Health Technology Assessment]. [PDF]

J Prev Med Hyg, 2023
Calabrò GE, Vitale F, Rizzo C, Pugliese A, Boccalini S, Bechini A, Panatto D, Amicizia D, Domnich A, Amodio E, Costantino C, DI Pietro ML, Salvati C, D'Ambrosio F, Orsini F, Maida A, Dominici A, Clemente D, Cecci M, Pellacchia A, DI Serafino F, Bakker K, Malik TM, Sharomi O, Belluzzo M, Leonforte F, Zagra L, LA Gatta E, Petrella L, Bonanni P, DE Waure C.   +30 more
europepmc   +1 more source